These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 3291233

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Combination therapy of cyclosporine and azathioprine in living-related kidney transplant recipients compared with patients converted totally from cyclosporine to azathioprine.
    Oka T, Omori Y, Aikawa I, Yasumura T, Yoshimura N, Nakai I.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):143-6. PubMed ID: 3291229
    [No Abstract] [Full Text] [Related]

  • 4. A prospective study of conversion from cyclosporine to azathioprine: comparison of clinical and morphologic findings.
    Abbud-Filho M, Ramalho HJ, Barberato JB, Corrente JE, Salgueiro MC, Mazzetto MR, Bezas AG.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):164-8. PubMed ID: 3291235
    [No Abstract] [Full Text] [Related]

  • 5. Long-term results of cadaveric renal transplantation after conversion from cyclosporine to azathioprine: a controlled randomized trial.
    Spielberger M, Aigner F, Schmid T, Bösmüller C, Königsrainer A, Margreiter R.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):169-70. PubMed ID: 3291236
    [No Abstract] [Full Text] [Related]

  • 6. Adjunctive azathioprine and antilymphocyte serum immunosuppression with cyclosporine.
    Ford HR, Fryd DS, Canafax DM, Ascher NL, Dunn D, Sutherland DE, Najarian JS, Simmons RL.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):8-12. PubMed ID: 3291316
    [No Abstract] [Full Text] [Related]

  • 7. Conversion from cyclosporine: status after five years.
    Freedman BI, Tuttle AB, Lorentz WB, Browning MC, Meredith JH, Burkart JM, Adams PL.
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1020-2. PubMed ID: 1989144
    [No Abstract] [Full Text] [Related]

  • 8. Intravenous cyclosporine to induce immunosuppression in cardiac allograft recipients.
    Macris MP, Frazier OH, Van Buren CT, Duncan JM.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):311-5. PubMed ID: 3291261
    [No Abstract] [Full Text] [Related]

  • 9. A prospective study of cyclosporine monitoring in renal transplantation.
    Lindholm A.
    Transplant Proc; 1990 Jun; 22(3):1260-3. PubMed ID: 2190388
    [No Abstract] [Full Text] [Related]

  • 10. [Spontaneous kidney transplant rupture--effect of immunosuppressive therapy on incidence of rupture].
    Oesterwitz H, Strobelt V, May G, Horlbeck R.
    Z Urol Nephrol; 1990 Apr; 83(4):157-63. PubMed ID: 2378176
    [Abstract] [Full Text] [Related]

  • 11. Conversion from cyclosporine to azathioprine after renal transplantation: long-term effects on renal function, rejection, and allograft survival.
    Maddux MS, Veremis SA, Bauma WD, Pollak R, Mozes MF.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):152-4. PubMed ID: 3291231
    [No Abstract] [Full Text] [Related]

  • 12. Triple drug immunosuppression (cyclosporine, azathioprine and low-dose prednisolone): a safe and effective regimen in first-cadaver kidney transplantation.
    Mourad G, Legendre C, Argiles A, Bonardet A, Mion C.
    Transplant Proc; 1987 Oct; 19(5):3672-3. PubMed ID: 3313886
    [No Abstract] [Full Text] [Related]

  • 13. The case against conversion to azathioprine in cyclosporine-treated renal recipients.
    Flechner SM, Lorber M, Van Buren C, Kerman R, Kahan BD.
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):276-81. PubMed ID: 3895667
    [No Abstract] [Full Text] [Related]

  • 14. Triple therapy with low-dose cyclosporine, azathioprine, and steroids: long-term results of a randomized study in cadaver donor renal transplantation.
    Fries D, Hiesse C, Santelli G, Gardin JP, Cantarovich M, Lantz O, Charpentier B, Paillard M, Benoit G.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):130-5. PubMed ID: 3291226
    [No Abstract] [Full Text] [Related]

  • 15. Renal transplants maintained on low-dose cyclosporine and prednisolone.
    Rogerson ME, Neild GH, Rudge CJ, Wood SM, Cairns HS, Mansell MA, Thompson FD.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):114-6. PubMed ID: 3291222
    [No Abstract] [Full Text] [Related]

  • 16. Cyclosporine treatment with conversion after three months is a safe treatment protocol in renal allograft recipients.
    Hoitsma AJ, Tiggeler RG, Wetzels JF, Berden JH, Koene RA.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):161-3. PubMed ID: 3291234
    [No Abstract] [Full Text] [Related]

  • 17. [4-way immunosuppression in pre-sensitized recipients of allogenic cadaver kidney transplants].
    Oesterwitz H, May G, Müller P, Strobelt V, Seeger W, Seibt F, Horlbeck R, Hansen C.
    Z Urol Nephrol; 1990 Jan; 83(1):1-8. PubMed ID: 2184625
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. First month cyclosporine A sparing in renal transplantation.
    Segoloni GP, Messina M, Colla L, Piccoli GB, Triolo G, Vercellone A.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):233-8. PubMed ID: 3291249
    [No Abstract] [Full Text] [Related]

  • 20. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients.
    Paraiso AR, Ona ET, Alano FA, Ramos CP, De Luna M.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.